Colorectal Cancer Survivors' Needs and Preferences for Survivorship Information

November 26, 2014 updated by: Memorial Sloan Kettering Cancer Center
We are doing this study to learn more about colon and rectal cancer survivors. We want to know if survivors want more information about life after cancer. Do cancer survivors want to know more about their own cancer? Do cancer survivors want to know about their treatment? Do cancer survivors want to know what health care they should get in the future? We want to know what information to give to cancer survivors when they finish treatment.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

177

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • New York
      • Jamaica, New York, United States, 11432
        • Queens Cancer Center of Queens Hospital
      • New York, New York, United States, 10065
        • Memorial Sloan-Kettering Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adults who completed treatment for nonmetastatic colorectal cancer at MSKCC or at Queens Cancer Center (QCC) at Queens Hospital

Description

Inclusion Criteria:

  • 18 years of age or older at diagnosis
  • Diagnosed with first primary colorectal cancer (stage I-III)
  • Completed last treatment for colorectal cancer (surgery, chemotherapy, or radiation) at least 6 months and no more than 2 years before the date of study enrollment
  • Able to speak English, because questionnaire is only available in English
  • Able to provide informed consent
  • Received all treatment for colorectal cancer at MSKCC or QCC or, surgical treatment at an outside facility, and all other treatment (chemotherapy or radiation) at MSKCC or QCC

Exclusion Criteria:

  • Undergoing active treatment for colorectal cancer
  • Diagnosed with metastatic colorectal cancer
  • Prior history of colorectal or any other cancer (except non-melanoma skin cancer)
  • Diagnosed with new or recurrent colorectal or other cancer after the primary colorectal cancer diagnosis
  • Received a survivorship care plan from the treating institution

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Questionnaire
This study is a cross-sectional survey study to be administered to adults who completed treatment for nonmetastatic colorectal cancer at MSKCC or at Queens Cancer Center (QCC) at Queens Hospital between 6 months and 2 years ago and have no evidence of disease at the time of study enrollment.
Behavioral: Questionnaire
The questionnaire will be administered by telephone and will take approximately 20-30 minutes. The questionnaire will elicit survivor responses along five domains: knowledge about diagnosis and treatment, knowledge about ongoing risks and recommended testing, history of health care utilization since the end of treatment, preferences for relevant information about these topics, and employment after the end of cancer treatment.
Other Names:
  • The questionnaire will be administered using a Computer Assisted Telephone Interview (CATI)
  • system. The CATI form of the questionnaire enables the interviewer to read aloud from a script and
  • enter responses into the computer in real-time, regardless of whether the interview is conducted on the
  • phone or in person. The CATI form of the questionnaire enables the interviewer to read aloud from a
  • script and enter responses into the computer in real-time, regardless of whether the interview is
  • conducted on the phone or in person.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Assess colorectal cancer survivors' basic knowledge of their own cancer history, including date of diagnosis, stage, and treatments received.
Time Frame: 6 months to 2 years after completion of treatment
6 months to 2 years after completion of treatment

Secondary Outcome Measures

Outcome Measure
Time Frame
Assess survivors' knowledge of medical issues relevant to colorectal cancer survivors.
Time Frame: 6 months to 2 years after completion of treatment
6 months to 2 years after completion of treatment
Describe the types of health care providers that survivors have visited since completing treatment for colorectal cancer.
Time Frame: 6 months to 2 years after completion of treatment
6 months to 2 years after completion of treatment
Assess survivors' preferences for the content, format, and delivery of survivorship care plans.
Time Frame: 6 months to 2 years after completion of treatment
6 months to 2 years after completion of treatment
Assess whether survivors who had concerns about working after cancer treatment spoke with health care professionals about their concerns.
Time Frame: 6 months to 2 years after completion of treatment
6 months to 2 years after completion of treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

Queens Cancer Center of Queens Hospital

Investigators

  • Principal Investigator: Talya Salz, PhD, Memorial Sloan Kettering Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2009

Primary Completion (Actual)

November 1, 2014

Study Completion (Actual)

November 1, 2014

Study Registration Dates

First Submitted

October 28, 2009

First Submitted That Met QC Criteria

October 28, 2009

First Posted (Estimate)

October 29, 2009

Study Record Updates

Last Update Posted (Estimate)

December 2, 2014

Last Update Submitted That Met QC Criteria

November 26, 2014

Last Verified

November 1, 2014

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 09-133

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rectal Cancer

Clinical Trials on Questionnaire

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe